Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) SHH

Currency In CNY

AD

Valuation

Market Cap7.99B
Enterprise Value6.25B
P/E Ratio22.78
PEG Ratio1
Price/Sales Ratio2.1
Price/Book Ratio1.4
Enterprise/Revenue1.65
Enterprise/EBITDA10.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue3.27B
Revenue/Share5.85
Gross Profit2.28B
EBITDA447.85M
Net Income303.93M
Diluted EPS0.54

Balance Sheet

Total Cash1.96B
Total Cash/Share3.46
Total Debt445.33M
Total Debt/Equity0.09
Current Ratio1.92
Book Value Per Share9.37

Price History

52-Week Change-19.08
52-Week High16.61
52-Week Low10.69
Moving Average 50 Days12.49
Moving Average 200 Days13.33

Statistics

Average Volume8.53M
Shares Outstanding566.16M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor6:5
Last Split DateJune 24, 2016
AD